ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $30,000 | -21.1% | 1,963 | +15.1% | 0.00% | 0.0% |
| Q1 2018 | $38,000 | -2.6% | 1,706 | +33.1% | 0.00% | 0.0% |
| Q4 2017 | $39,000 | +5.4% | 1,282 | +31.2% | 0.00% | 0.0% |
| Q3 2017 | $37,000 | +60.9% | 977 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $23,000 | +155.6% | 837 | +224.4% | 0.00% | – |
| Q1 2017 | $9,000 | +28.6% | 258 | +1.6% | 0.00% | – |
| Q4 2016 | $7,000 | -12.5% | 254 | +4.1% | 0.00% | – |
| Q3 2016 | $8,000 | 0.0% | 244 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | – | 244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |